Interestingly, recombinant OPG has been shown to completely prevent osteolytic metastatic lesions caused by MDA-MB-231 human breast cancer cells in nude and ovariectomized mice [121, 122]. This evidence concerns the gene TNFRSF11B and breast cancer.